Structure-guided identification and experimental validation of NAT10-targeting small molecules in colorectal cancer cells
G856-6814 is supported as a NAT10-targeting inhibitory scaffold that requires broader selectivity and in vivo evaluation and attenuation of cellular effects after NAT10 knockdown.